Class 2 Recall-WockAIR 160 microgram/4.5 microgram, inhalation powder

Wockhardt UK Limited is recalling this batch as a precautionary measure following the identification of a low number of units which may have a defect in the 'top case' resulting in a dose not being able to be dispensed.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-wockhardt-uk-limited-wockair-160-microgram-slash-4-dot-5-microgram-inhalation-powder-el-24-a-slash-62?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=196509da-279d-4663-b40b-c3c0cadad8aa&utm_content=immediately

Further information

For medical information enquiries please telephone 01978 661261 and ask for ‘drug safety’, or email drug.safety@wockhardt.co.uk.

For stock control enquiries please telephone 01978 661261 and ask for ‘customer services’, or email group_uk_csu@wockhardt.co.uk.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited).

Please note that anything not returned to us, or notified to us, within 12 weeks of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Liothyronine Sodium tablets 5mcg and 20mcg

Strides Pharma UK Ltd has informed MHRA of an error in the patient information leaflet (PIL) for Liothyronine Sodium 20 micrograms Tablets and Liothyronine Sodium 5 micrograms Tablets.

MHRA Drug alert date: 28th November 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-strides-pharma-uk-ltd-liothyronine-sodium-5-and-20-micrograms-tablets-el-24-a-slash-58?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=1b6cc57b-c4b2-4d42-b911-de0ebf43fd1b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact Strides Pharma UK Ltd via email dl-drugsafety@strides.com or telephone +919844460742

For stock control enquiries please contact Strides Pharma UK Ltd via email customerservicesuk@stridespharma.co.uk or telephone 01923 255580

Class 4 caution in use-Oxybutynin hydrochloride Brillpharma 2.5 mg/5 ml Oral Solution

L M Manufacturing Limited has informed the MHRA that the patient information leaflet (PIL) in the cartons for the batch listed for Oxybutynin hydrochloride Brillpharma 2.5 mg/5 ml Oral Solution include an out of date PIL, dated July 2021.

MHRA Drug alert date: 4th December 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-brillpharma-limited-oxybutynin-hydrochloride-brillpharma-2-dot-5-mg-slash-5-ml-oral-solution-el-24-a-slash-61?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=65edb208-204d-4796-8f38-9e6cee8a828f&utm_content=immediately

This is a caution in use only we are not accepting stock returns

For medical information enquiries please contact info@brillpharma.co.uk.

For stock control enquiries please contact Telephone +44 (0) 1582 545500

Class 3 recall-Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free

Kent Pharma UK is recalling a batch of phenoxymethylpenicillin 250mg/5mL oral solution sugar free due to a low phenoxymethylpenicillin assay.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-kent-pharma-uk-phenoxymethylpenicillin-250mg-slash-5ml-oral-solution-sugar-free-el-24-a-slash-60

Further Information

For medical information enquiries please contact medical@kent-athlone.com

For stock control enquiries please contact customer.service@kent-athlone.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Mycophenolate Mofetil 1g / 5ml Oral Suspension

Rosemont Pharmaceuticals Limited has informed the MHRA that the Press-In-Bottle-Adaptor (PIBA) supplied with the batches listed above may cause the medicine to leak when attempting to withdraw a dose.

MHRA Drug alert date: 2nd December 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-rosemont-pharmaceuticals-limited-mycophenolate-mofetil-1g-slash-5ml-oral-suspension-el-24-a-slash-59

This is a caution in use only we are not accepting stock returns

For medical information enquiries please contact pharmacovigilance@rosemontpharma.com, or telephone 0113 244 1400.

For stock control enquiries please contact customerservices@rosemontpharma.com, or telephone 0113 244 1999.

Class 4 caution in use-Tramadol 50 mg capsules & PR capsules

Morningside Healthcare Limited has informed the MHRA of a packaging issue identified in batch MRA2303 of Tramadol Hydrochloride Morningside 50 mg Prolonged-Release Capsules and batch MRF2301 of Tramadol Hydrochloride 50 mg Capsules.

MHRA Drug alert date: 27th November 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-morningside-healthcare-limited-tramadol-hydrochloride-50-mg-capsules-and-tramadol-hydrochloride-morningside-50-mg-prolonged-release-capsules-el-24-a-slash-57

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries and reports of missing capsules or blister strips, please email medinfo@aspirepharma.co.uk or telephone 01730231148.

For all stock enquiries, please email mplcustomerservices@morningsidepharm.com or telephone 01730231148.

Class 3 recall-Baclofen 10mg/5ml Oral Solution

Syri Limited, T/A SyriMed is recalling this batch of product as a precautionary measure due to crystallisation observed over time in the oral solution.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-syri-limited-t-slash-a-syrimed-baclofen-10mg-slash-5ml-oral-solution-el-24-a-slash-56?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2211a202-bd3d-4594-97b7-810fe36e857b&utm_content=immediately

Further Information

For medical information enquiries please email medinfo@syrimed.co.uk, or telephone +44 (0) 330 1359 422.

For stock control enquiries please email syriwholesale@bnsthamelabs.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

field saftey notice-Silvercel And Tegaderm dressings

We have received a field safety notice from Advanced Medical Solutions (AMS) regarding batches of Silvercel and Tegaderm dressings

Date of recall:19/11/24

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Entyvio 108mg solution for injection in pre-filled syringe

Takeda UK Limited has informed the MHRA that there is an error in the Patient Information Leaflet for specified batches of Entyvio 108mg pre-filled syringes.

MHRA Drug alert date: 18th November 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-takeda-uk-limited-entyvio-108mg-solution-for-injection-in-pre-filled-syringe-el-24-a-slash-55?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=434da6dd-accb-44a3-8388-8e2c828f01ed&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please Email medinfoemea@takeda.com or telephone 03333 000 181

For stock control enquiries please Email ukie.supplychain@takeda.com

Company-led recall: EXS Delay Spray Plus

LTC Healthcare has informed the MHRA that they have been selling a medicinal product containing lidocaine without authorisation from the MHRA.

MHRA Drug alert date: 13th November 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-leeds-trading-company-ltc-ltd-t-slash-a-ltc-healthcare-exs-delay-spray-plus-clmr-24-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f8d41c6d-9823-4127-9e84-7c0ff605722f&utm_content=immediately

Further Information

For medical information enquiries, please contact Andy Taylor, Managing Director:

Email: andy@ltchealthcare.co.uk

Telephone: 01423 326687

For stock information enquiries, please contact Andy Taylor, Managing Director:

Email: andy@ltchealthcare.co.uk

Telephone: 01423 326687